Grey Market Premium (GMP): Useful or Noise?

Most retail investors first meet GMP on a Telegram channel or an IPO website that updates a small green or red number every morning. The number looks scientific. The discussion around it sounds confident. The implication is that someone, somewhere, has already decided what the stock is worth before the rest of us see it.

A beginner does not chase that number because they are careless. They chase it because the number seems to reduce uncertainty. A +₹60 GMP feels like someone has already done the homework for you. The danger is that the number feels precise even when the process behind it is not.

That is the part worth examining honestly. The grey market is real in the sense that money does change hands. It is also small, opaque and easily moved, which is why the honest answer to "is GMP useful or noise" is closer to noise than to useful for almost every retail investor reading this.

What GMP actually is, in one sentence

Strip the jargon and GMP is one sentence. It is the rupee premium a small group of dealers is currently willing to pay for an IPO allotment that has not yet been listed.

The trade itself is verbal. Buyer and seller agree on the premium over the phone or on WhatsApp, the allotment is delivered on listing day, and the cash settles in person. There is no exchange ticker, no order book and no daily settlement statement. The premium drifts during the issue window as the dealers update each other on what they think the listing will do.

The market is concentrated, not broad. Activity sits in a small dealer network spread across a handful of Indian cities, operating through phone calls and WhatsApp rather than exchange terminals. The same names often appear on both sides of trades, which is the opposite of the broad, anonymous auction that listing day will produce.

Compare that to the official IPO process. The merchant banker — the investment bank running the issue — collects bids in four categories: QIB (large institutions like mutual funds and insurers), NII (high-net-worth individuals bidding above ₹2 lakh), retail and anchor. The exchange aggregates the bids, and the basis-of-allotment is a SEBI-regulated process anyone can audit later. In oversubscribed retail categories, allotment is randomised, which is why it can feel lottery-like.

By the time you see the GMP on a website, the actual decision-makers, the ones with thousands of crores to deploy, have already shown their hand in subscription data that anyone can read.

How the GMP number actually forms

To understand why GMP behaves the way it does, walk through how the number is born and updated during a single IPO week.

1. T minus 3

   Issue is announced

   Once the price band is filed with SEBI, a few large dealers put out the first quote, often before retail can even apply. The number is mostly a rough sentiment check against similar listed peers and recent IPO listing pops.

2. T minus 1

   Anchor list is filed

   The night before the issue opens, the merchant banker releases the anchor investor list. The GMP often jumps or drops noticeably in a single day based on which names show up, since dealers read it as a signal of how much institutional demand will follow.

3. Day 1 to 3

   Subscription window, GMP gets noisy

   During the three-day window, the quote moves with WhatsApp forwards, finfluencer takes and rumours about QIB demand. A handful of dealers can move the number by ten rupees in either direction with a few phone calls, especially on smaller issues where the float is thin.

4. T plus 5

   Allotment day, often the peak

   Once allotment is finalised, sellers with successful allotments and buyers who failed start trading. Quotes peak right here because the market is most liquid for the briefest moment. Then quotes drift again as listing approaches.

5. Listing day

   The grey market closes

   The exchange call auction sets the real opening price. Grey market trades settle in cash on the same day, the spreadsheet on the website goes blank, and the GMP number stops mattering. The actual listing price is what gets recorded and remembered.

Two old terms still float around in this market. Kostak is the flat rupee price paid for the application itself, regardless of whether shares are allotted — think of it as buying the lottery ticket. Subject-to-sauda is the premium paid only if shares are actually allotted — buying the prize only when the ticket wins. Both are settled in cash on listing day, and both depend entirely on the seller honouring the verbal commitment.

Two GMP websites can show different numbers on the same morning for the same IPO. That alone tells you most of what you need to know about how the number is sourced.

GMP is opinion, subscription is action

The cleanest way to think about GMP is as a sentiment indicator. It tells you what a small, self-selected group of dealers thinks the stock might do on day one. It does not tell you what the company is worth, what it will earn, or what institutions have already committed to pay.

Set that against the official subscription data the exchanges publish every evening of the issue window, and the contrast is sharp. If a ₹1,000 crore issue receives ₹10,000 crore of QIB bids, that is ten times institutional demand — a real, auditable, time-stamped signal that no grey-market quote can match.

QIB demand on the final day is one of the cleanest official signals a retail investor can read. When mutual funds and insurance companies have put real money on the table at the cut-off price, they are saying they think the issue is worth at least that. When that pool is undersubscribed in the final hours, the green GMP number on a website is fighting a much bigger signal — treat the weakness in QIB as a red flag and ask what those institutions are seeing that the grey market is not.

The anchor list is the second useful read. Anchors lock in the price the night before the issue opens, and under SEBI rules they cannot exit for thirty days on half their holding, and ninety days on the rest. A list with three or four marquee mutual funds is real conviction. A list dominated by small unknown funds is something else.

Why GMP misleads as often as it helps

The strongest case against GMP is the recent record on the issues most retail investors actually applied for. The big names that made headlines, the ones where GMP was loudest, are also the ones where the GMP was most wrong.

Paytm in 2021. The grey market quoted a positive premium right up until listing. The stock opened around nine percent below the issue price of ₹2,150 and closed the first day down roughly twenty-seven percent. Retail bidders who anchored on the GMP and not on the valuation watched a heavy first-day loss they had not been priced in to expect.

LIC in 2022. India's largest IPO ever. GMP slid from a small positive to negative across the issue week. The stock listed at ₹872 against an issue price of ₹949, an opening discount of about eight percent, and closed the first day down roughly the same amount.

The listing-day trader narrative dominated the news cycle. Three years later, the question of whether LIC was a good business at a fair price is being answered by the company's earnings, not by what the grey market said in May 2022.

The everyday case. Far less famous than Paytm or LIC, many small mainboard and SME IPOs every year carry a healthy positive GMP through the subscription window and then list flat or red. The dealers move on to the next issue. The retail investor who chased the GMP is left holding a stock at issue price, with no fundamental thesis to fall back on.

There are three structural reasons the GMP is unreliable for retail.

The float is small. Only a small number of shares ever change hands in the grey market for a typical mainboard issue. The number on the website is what those few trades cleared at, often with the same handful of dealers on both sides. A real exchange call auction on listing day involves many more participants and far deeper capital.

Dealers have their own position. Many of the people quoting the GMP also hold an allotment they want to sell on listing day. Talking the GMP up by even a few rupees can pay for itself many times over. The incentive to influence the published number is real, and the cost of doing so is essentially zero.

Survivorship bias in the memory. Retail investors remember the IPO where the GMP was right and they got a quick listing pop. They forget the four IPOs in the same month where the GMP was right too but small, and the two where it was completely wrong. The mental scorecard makes GMP look more accurate than the actual record.

What to read instead of GMP

If you remove the GMP screenshot from your IPO research, what replaces it? Four signals, all public, all auditable, all sourced from documents the merchant banker and the exchanges actually file with SEBI.

Subscription by category. The exchanges publish this every evening of the issue window. Look at QIB on the final day, then NII, then retail. If QIB is undersubscribed when the issue closes, treat it as a major red flag and look for a clear reason in the RHP before applying — a green GMP is not a substitute for institutional money on the table.

The anchor investor list. Filed the night before the issue opens. Read which mutual funds, insurance companies and FPIs (foreign portfolio investors) have committed, and at what allocation. Real names putting real money on the table the day before retail bids matters far more than any dealer's quote.

The red herring prospectus. The promoter holding before and after the IPO, the use of proceeds, the offer-for-sale portion versus fresh issue, the related-party transactions and the litigation history. A skim of these sections tells you whether the issue is about raising growth capital or letting existing holders cash out.

Listed peer comparison. If the issue is priced richer than every listed company in the same sector, the listing pop has to come from somewhere. A peer-relative valuation read on the morning of the issue is worth more than a week of GMP screenshots.

None of these are secret. They sit in the public domain, filed with SEBI and the exchanges, and most of them are summarised in any decent research note. The work of reading them is what separates retail investors who survive a hot IPO market from the ones who get repeatedly punished by it.